Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling.

Martín, M; de la Torre-Montero, J C; López-Tarruella, S; Pinilla, K; Casado, A; Fernandez, S; Jerez, Y; Puente, J; Palomero, I; González Del Val, R; Del Monte-Millan, M; Massarrah, T; Vila, C; García-Paredes, B; García-Sáenz, J A; Lluch, A

Martín, M; de la Torre-Montero, J C; López-Tarruella, S; Pinilla, K; Casado, A; Fernandez, S; Jerez, Y; Puente, J; Palomero, I; González Del Val, R; Del Monte-Millan, M; Massarrah, T; Vila, C; García-Paredes, B; García-Sáenz, J A; Lluch, A.

Afiliação

Martín M; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain. mmartin@geicam.org.
de la Torre-Montero JC; Hospital General Universitario Gregorio Marañón, Medical Oncology Service, Calle Maiquez, no. 9, 28007, Madrid, Spain. mmartin@geicam.org.
López-Tarruella S; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
Pinilla K; Universidad Pontificia Comillas, Madrid, Spain.
Casado A; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
Fernandez S; Medical Oncology Department, Hospital Clínico Universitario, CIBERONC, Valencia, Spain.
Jerez Y; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
Palomero I; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
González Del Val R; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
Del Monte-Millan M; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
Massarrah T; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
Vila C; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
García-Paredes B; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
García-Sáenz JA; Medical Oncology Service, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Madrid, Spain.
Lluch A; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.

Breast Cancer Res Treat ; 171(3): 635-636, 2018 10.

Article em En | MEDLINE | ID: mdl-30009323

ABSTRACT

ABSTRACT

In the original publication of the article, Table 1 was published with incorrect caption and values. The Table 1 with corrected caption and values is given in this Correction.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google